|
| Status |
Public on Jun 22, 2018 |
| Title |
POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
29945888 |
| NIH grant(s) |
| Grant ID |
Grant title |
Affiliation |
Name |
| P30 CA045508 |
CSHL CANCER CENTER SUPPORT GRANT |
COLD SPRING HARBOR LABORATORY |
BRUCE W. STILLMAN |
| R01 CA174793 |
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia |
COLD SPRING HARBOR LABORATORY |
CHRISTOPHER VAKOC |
|
| |
| Submission date |
May 30, 2018 |
| Last update date |
Mar 26, 2019 |
| Contact name |
Olaf Klingbeil |
| E-mail(s) |
[email protected]
|
| Organization name |
Cold Spring Harbor Laboratory
|
| Street address |
1 Bungtown Road
|
| City |
Cold Spring Harbor |
| State/province |
New York |
| ZIP/Postal code |
11724 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (88)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE115122 |
POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer [RNA-seq] |
| GSE115123 |
POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer [ChIP-seq] |
|
| Relations |
| BioProject |
PRJNA473826 |
Less...
More...